Amarin Corporation plc (AMRN) Price & News - Google Finance (2024)

Markets

US

Europe

Asia

Currencies

Crypto

Futures

DAX18,341.89+0.58%+106.44DAX18,341.890.58%
FTSE 1008,201.34+0.46%+37.22FTSE 1008,201.340.46%
CAC 407,637.29+2.11%+157.89CAC 407,637.292.11%
IBEX 3511,091.90+1.35%+148.20IBEX 3511,091.901.35%
STOXX 504,957.94+1.31%+63.92STOXX 504,957.941.31%

HomeAMRN • NASDAQ

Amarin Corporation plc

$0.69

Jul 1, 4:00:00 AM GMT-4 · USD · NASDAQ · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Amazon.com Inc

$193.25

AMZN2.32%

Akebia Therapeutics Inc

$1.02

AKBA3.11%

RedHill Biopharma Ltd

$0.37

RDHL1.72%

Aurinia Pharmaceuticals Inc

$5.71

AUPH1.60%

Sangamo Therapeutics Inc

$0.36

SGMO10.11%

FuelCell Energy Inc

$0.64

FCEL0.078%

Crispr Therapeutics AG

$54.01

CRSP2.47%

Biogen Inc

$231.82

BIIB1.36%

Heron Therapeutics Inc

$3.50

HRTX2.64%

Ardelyx Inc

$7.41

ARDX14.00%

Financials

Income Statement

Revenue

Net income

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/1/24.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

56.52M-34.26%

Operating expense

Represents the total incurred expenses through normal operations

45.49M-30.31%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-9.95M39.53%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

-17.618.04%

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

-0.01-150.00%

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-12.82M-196.65%

Effective tax rate

The percent of their income that a corporation pays in taxes

-15.00%

Total assets

Total liabilities

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/1/24.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

308.18M1.25%

Total assets

The total amount of assets owned by a company

790.01M-8.16%

Total liabilities

Sum of the combined debts a company owes

244.08M-11.37%

Total equity

The value of subtracting the total liabilities from the total assets of a company

545.94M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

410.87M

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

0.53

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-4.19%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

-6.07%

Net change in cash

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/1/24.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-9.95M39.53%

Cash from operations

Net cash used or generated for core business activities

-12.60M-79.81%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

28.72M246.45%

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

-1.43M-491.76%

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

14.69M155.96%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

-12.69M6.80%

US listed security

Listed on NASDAQ

IE headquartered

Headquartered in Dublin, Leinster, Ireland

Previous close

The last closing price

$0.70

Day range

The range between the high and low prices over the past day

$0.69 - $0.71

Year range

The range between the high and low prices over the past 52 weeks

$0.63 - $1.49

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

281.95M USD

Avg Volume

The average number of shares traded each day over the past 30 days

1.81M

About

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia

CEO

Karim Mikhail

Founded

Mar 1, 1989

Headquarters

Dublin, LeinsterIreland

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexDow Jones Industrial Average39,118.860.12%
ISPIntesa Sanpaolo SpA€3.552.35%
AMZNAmazon.com Inc$193.252.32%
IndexEURO STOXX 504,957.941.31%
TSLATesla Inc$197.880.23%
IndexDAX PERFORMANCE-INDEX18,341.890.58%
IndexNasdaq-10019,682.870.54%
AAPLApple Inc$210.621.63%
UCGUniCredit SpA€35.693.14%
IndexNasdaq Composite17,732.600.71%
IndexVIX13.026.37%
IndexFTSE 100 Index8,201.340.46%
ENIEni SpA€14.521.18%
LDOLeonardo SpA€21.780.46%
ENELEnel S.p.A. Ordinary Shares€6.601.60%
GAssicurazioni Generali SpA€23.772.06%
IndexSTOXX Europe 600515.560.81%

People also search for

AMZNAmazon.com Inc$193.252.32%
AKBAAkebia Therapeutics Inc$1.023.11%
RDHLRedHill Biopharma Ltd$0.371.72%
AUPHAurinia Pharmaceuticals Inc$5.711.60%
SGMOSangamo Therapeutics Inc$0.3610.11%
FCELFuelCell Energy Inc$0.640.078%
CRSPCrispr Therapeutics AG$54.012.47%
BIIBBiogen Inc$231.821.36%
HRTXHeron Therapeutics Inc$3.502.64%
ARDXArdelyx Inc$7.4114.00%
ANIPANI Pharmaceuticals Inc Common Stock$63.680.94%
GLYCGlycoMimetics Inc$0.2811.22%
MNKDMannKind Corp$5.221.32%
BMYBristol-Myers Squibb Co$41.530.048%
MCRBSeres Therapeutics Inc$0.727.80%
ESPREsperion Therapeutics Inc$2.223.90%
BNGOBioNano Genomics Inc$0.687.69%
AAPLApple Inc$210.621.63%

Amarin Corporation plc (AMRN) Price & News - Google Finance (3)HelpSend feedbackPrivacyTermsDisclaimer

Amarin Corporation plc (AMRN) Price & News - Google Finance (2024)
Top Articles
Latest Posts
Article information

Author: Domingo Moore

Last Updated:

Views: 5884

Rating: 4.2 / 5 (73 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Domingo Moore

Birthday: 1997-05-20

Address: 6485 Kohler Route, Antonioton, VT 77375-0299

Phone: +3213869077934

Job: Sales Analyst

Hobby: Kayaking, Roller skating, Cabaret, Rugby, Homebrewing, Creative writing, amateur radio

Introduction: My name is Domingo Moore, I am a attractive, gorgeous, funny, jolly, spotless, nice, fantastic person who loves writing and wants to share my knowledge and understanding with you.